The END Fund

The End Fund


Senior Director: Laura Parrotta
Established: 2012
Type: Charity
Focus Region: Global
Sectors: Health


The END Fund is the only private philanthropic initiative dedicated to ending the five most common neglected tropical diseases (NTDs) – a group of parasitic and bacterial infectious diseases, such as river blindness and intestinal worms. By engaging a community of activist-philanthropists and taking a systems approach, we are working in collaboration with governments, NGOs, pharmaceutical, and academic partners to end these diseases in our lifetime. Since our founding in 2012 through 2020, with our partners, the END Fund has provided over 1 billion treatments for NTDs worth more than $1.3 billion. In 2020 alone, we reached more than 91 million people with more than 133 million NTD treatments, which represents an almost 8-fold increase from 2012.


Control and eliminate the most prevalent neglected diseases.


To ensure people at risk of neglected tropical diseases can live healthy and prosperous lives.


The END Fund manages a portfolio of programmatic funds as investment opportunities for private philanthropists, foundations, corporations, and others. The Flagship Fund, our founding investment vehicle, is centered around inclusion, high impact, and flexibility. The Fund aims to deliver NTD treatment in a highly cost-effective way, ensuring maximum return on investment for every dollar spent. The fund applies best practices in the sector and rolls-out new technologies and innovations at scale to reach control and elimination goals.

The Deworming Innovation Fund aims to accelerate progress toward eliminating parasitic worms in four African countries by 2025. It will complement commitments made by local leaders to ensure that nobody in need of deworming treatment is left behind and that programs reach at-risk population groups not often reached through treatment campaigns.

The Reaching the Last Mile Fund is a ten-year, multi-donor fund dedicated to the elimination of river blindness and lymphatic filariasis. The RLMF is initiated by His Highness Sheikh Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi, in collaboration with the Bill & Melinda Gates Foundation, with additional support from a diverse group of philanthropic, corporate, and government funders.


Translate »